StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.

Inhaled anesthetics punch well above their weight when it comes to generating greenhouse gases, so the specialty of anesthesiology has been trying to reduce its reliance on the most egregious of ...

Perioperative celecoxib, combined with opioids, is an effective and safe regimen for pain control in TKA patients. Perioperative celecoxib can significantly decrease postoperative pain scores at ...